Stem Cell And Tissue Engineering Research Profile
Key Indicators
- Authorised Capital ₹ 4.10 M
- Paid Up Capital ₹ 4.07 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Profit Growth 60.72%
- Ebitda 70.38%
- Net Worth -0.36%
- Total Assets %
About Stem Cell And Tissue Engineering Research
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KA2011PTC061274
-
Company No.
061274
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 2011
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Stem Cell And Tissue Engineering Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shama Bhat
|
Managing Director | 22-Nov-2011 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Susheela Bhat
|
Director | 22-Nov-2011 | Current |
Financial Performance of Stem Cell And Tissue Engineering Research.
Stem Cell And Tissue Engineering Research Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 60.72% increase in profit. The company's net worth dipped by a decrease of 0.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stem Cell And Tissue Engineering Research?
In 2017, Stem Cell And Tissue Engineering Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bhat Bio-Tech India Private LimitedShama Bhat and Susheela Bhat are mutual person
-
Navachethan Retirement Residency Private LimitedShama Bhat and Susheela Bhat are mutual person
-
Bhat Bio-Tech Healthcare Private LimitedShama Bhat and Susheela Bhat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stem Cell And Tissue Engineering Research?
Unlock and access historical data on people associated with Stem Cell And Tissue Engineering Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stem Cell And Tissue Engineering Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stem Cell And Tissue Engineering Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
